Selective serotonin reuptake inhibitors (SSRIs) are commonly used in DPDR treatment, primarily targeting serotonin neurotransmission to modulate emotional processing and reduce symptoms. By increasing synaptic serotonin levels, these medications can help alleviate anxiety, normalize perception, and potentially interrupt the neurological mechanisms underlying depersonalization and derealization experiences.